These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 7982765)
1. Is a random urinary albumin concentration a useful screening test in insulin-treated diabetic patients? Beatty OL; Ritchie CM; Hadden DR; Kennedy L; Bell PM; Atkinson AB Ir J Med Sci; 1994 Sep; 163(9):406-9. PubMed ID: 7982765 [TBL] [Abstract][Full Text] [Related]
2. Microalbuminuria as identified by a spot morning urine specimen in non-insulin-treated diabetes: an eight-year follow-up study. Beatty OL; Ritchie CM; Bell PM; Hadden DR; Kennedy L; Atkinson AB Diabet Med; 1995 Mar; 12(3):261-6. PubMed ID: 7758264 [TBL] [Abstract][Full Text] [Related]
3. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. Powrie JK; Watts GF; Ingham JN; Taub NA; Talmud PJ; Shaw KM BMJ; 1994 Dec; 309(6969):1608-12. PubMed ID: 7819935 [TBL] [Abstract][Full Text] [Related]
4. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care. Agardh CD; Agardh E; Torffvit O Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466 [TBL] [Abstract][Full Text] [Related]
5. Microalbuminuria in diabetes mellitus: efficacy of a new screening method in comparison with timed overnight urine collection. Meinhardt U; Ammann RA; Flück C; Diem P; Mullis PE J Diabetes Complications; 2003; 17(5):254-7. PubMed ID: 12954153 [TBL] [Abstract][Full Text] [Related]
6. Microalbuminuria in insulin-dependent diabetes: prevalence and practical consequences. Niazy S; Feldt-Rasmussen B; Deckert T J Diabet Complications; 1987; 1(3):76-80. PubMed ID: 2969909 [TBL] [Abstract][Full Text] [Related]
7. Prior long term glycaemic control and insulin therapy in insulin-dependent diabetic adolescents with microalbuminuria. Kalk WJ; Osler C; Taylor D; Panz VR Diabetes Res Clin Pract; 1990 Apr; 9(1):83-8. PubMed ID: 2190783 [TBL] [Abstract][Full Text] [Related]
8. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group. Diabetologia; 1996 May; 39(5):587-93. PubMed ID: 8739919 [TBL] [Abstract][Full Text] [Related]
9. The relationship between the development and progression of microalbuminuria and arterial blood pressure in type 1 (insulin-dependent) diabetes mellitus. Raal FJ; Kalk WJ; Taylor DR; Osler CE; Panz VR Diabetes Res Clin Pract; 1992 Jun; 16(3):221-7. PubMed ID: 1425143 [TBL] [Abstract][Full Text] [Related]
10. The predictive value of microalbuminuria in IDDM. A five-year follow-up study. Almdal T; Nörgaard K; Feldt-Rasmussen B; Deckert T Diabetes Care; 1994 Feb; 17(2):120-5. PubMed ID: 8137681 [TBL] [Abstract][Full Text] [Related]
11. Microalbuminuria and clinical nephropathy in type 1 (insulin-dependent) diabetes mellitus: pathophysiological mechanisms and intervention studies. Feldt-Rasmussen B Dan Med Bull; 1989 Oct; 36(5):405-15. PubMed ID: 2680312 [No Abstract] [Full Text] [Related]
12. An examination of the covariability of subclinical albuminuria in insulin-dependent diabetes mellitus: implications for monitoring microalbuminuria. Watts GF; Taub NA; Mazurkiewicz J; Shaw KM Diabetes Res Clin Pract; 1993; 21(2-3):177-85. PubMed ID: 8269820 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics associated with microalbuminuria in an adult diabetic population. Tung P; Ginier P; Levin SR; Hershman JD; Hershman JM J Diabet Complications; 1990; 4(1):15-20. PubMed ID: 2141840 [TBL] [Abstract][Full Text] [Related]
14. How to predict nephropathy in type 1 diabetic patients. Dash R; Torffvit O Scand J Urol Nephrol; 2003; 37(5):437-42. PubMed ID: 14594696 [TBL] [Abstract][Full Text] [Related]
15. The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications. Chiarelli F; Verrotti A; Mohn A; Morgese G Ann Med; 1997 Oct; 29(5):439-45. PubMed ID: 9453292 [TBL] [Abstract][Full Text] [Related]
16. Practical aspects of measuring microalbuminuria in diabetic patients. Jermendy G; Farkas K; Nádas J; Daróczy A; Péterfai E Diabetes Nutr Metab; 2001 Aug; 14(4):195-200. PubMed ID: 11716288 [TBL] [Abstract][Full Text] [Related]
17. Intermittent microalbuminuria in children with type 1 diabetes mellitus without clinical evidence of nephropathy. Mullis P; Köchli HP; Zuppinger K; Schwarz HP Eur J Pediatr; 1988 May; 147(4):385-8. PubMed ID: 3294013 [TBL] [Abstract][Full Text] [Related]
18. Screening of diabetic patients for microalbuminuria in primary care--The PROSIT-Project. Proteinuria Screening and Intervention. Piehlmeier W; Renner R; Schramm W; Kimmerling T; Garbe S; Proetzsch R; Fahn J; Piwernetz K; Landgraf R Exp Clin Endocrinol Diabetes; 1999; 107(4):244-51. PubMed ID: 10433063 [TBL] [Abstract][Full Text] [Related]
19. Endothelial function and serum lipids in the course of developing microalbuminuria in insulin-dependent diabetes mellitus. Myrup B; Mathiesen ER; Rønn B; Deckert T Diabetes Res; 1994; 26(1):33-9. PubMed ID: 7664535 [TBL] [Abstract][Full Text] [Related]
20. Treatment with atenolol prevents progression of microalbuminuria in type I diabetic patients. Tindall H; Urquhart S; Stickland M; Davies JA Curr Med Res Opin; 1991; 12(8):516-20. PubMed ID: 1764955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]